News

The American Journal of Managed Care5d
DMD Gene Therapy Shows Clinical Benefits in 8- and 9-Year-Old Patients
The findings support the clinical benefits of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) ...
News Medical6y
Study findings hold promise for children with DMD
Heier, Ph.D., and Christopher F. Spurney, M.D., of Children's National Health System, is investigating cardiomyopathy in DMD. They find genetic dystrophin loss provides "a second hit" for a ...
Business Insider6y
DMD Shareholders Overwhelmingly Approve Plan of Arrangement
MONTREAL, Sept. 19, 2018 /CNW/ - DMD Digital Health Connections Group Inc. ("DMD") (NEX: DMG.H) is pleased to announce that the proposed plan of arrangement (the "Arrangement") with 10653365 ...
Nasdaq3y
Sarepta's (SRPT) DMD Gene Therapy Study Data Fails to Impress
The double-blind, placebo-controlled Study 102 is evaluating the safety, efficacy and tolerability of a single dose of SRP-9001 in 41 patients with DMD. Part 2 of the study evaluated SRP-9001 in ...
Nasdaq8y
Sarepta Stock Nearly Doubles on FDA Approval for DMD Drug
Shares of Sarepta Therapeutics, Inc.SRPT shot up 73.9% on Monday after the company announced that it has received accelerated approval for its Duchenne muscular dystrophy (DMD) drug, Exondys 51 ...